152 related articles for article (PubMed ID: 22555176)
21. Finding the root of the problem: the quest to identify melanoma stem cells.
Abel EV; Aplin AE
Front Biosci (Schol Ed); 2011 Jun; 3(3):937-45. PubMed ID: 21622243
[TBL] [Abstract][Full Text] [Related]
22. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
J Invest Dermatol; 2013 May; 133(5):1384-7. PubMed ID: 23389394
[No Abstract] [Full Text] [Related]
24. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
[TBL] [Abstract][Full Text] [Related]
25. [The role of intermedial filament nestin in malignant melanoma progression].
Brychtová S; Fiurásková M; Brychta T; Hirnák J
Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
[TBL] [Abstract][Full Text] [Related]
26. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
27. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
28. ABCB5 is a limbal stem cell gene required for corneal development and repair.
Ksander BR; Kolovou PE; Wilson BJ; Saab KR; Guo Q; Ma J; McGuire SP; Gregory MS; Vincent WJ; Perez VL; Cruz-Guilloty F; Kao WW; Call MK; Tucker BA; Zhan Q; Murphy GF; Lathrop KL; Alt C; Mortensen LJ; Lin CP; Zieske JD; Frank MH; Frank NY
Nature; 2014 Jul; 511(7509):353-7. PubMed ID: 25030174
[TBL] [Abstract][Full Text] [Related]
29. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
30. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
31. Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.
Saeed MEM; Boulos JC; Machel K; Andabili N; Marouni T; Roth W; Efferth T
In Vivo; 2022; 36(4):1651-1666. PubMed ID: 35738589
[TBL] [Abstract][Full Text] [Related]
32. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
33. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
34. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the roles of ABCB5 in normal and cancer cells.
Duvivier L; Gillet JP
Trends Cancer; 2022 Oct; 8(10):795-798. PubMed ID: 35907754
[TBL] [Abstract][Full Text] [Related]
36. The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.
Wagner N; Panelos J; Massi D; Wagner KD
Pflugers Arch; 2008 Feb; 455(5):839-47. PubMed ID: 17912546
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.
Pilloni L; Bianco P; Difelice E; Cabras S; Castellanos ME; Atzori L; Ferreli C; Mulas P; Nemolato S; Faa G
Eur J Histochem; 2011 Jun; 55(2):e20. PubMed ID: 22193299
[TBL] [Abstract][Full Text] [Related]
38. FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.
Romano S; Staibano S; Greco A; Brunetti A; Nappo G; Ilardi G; Martinelli R; Sorrentino A; Di Pace A; Mascolo M; Bisogni R; Scalvenzi M; Alfano B; Romano MF
Cell Death Dis; 2013 Apr; 4(4):e578. PubMed ID: 23559012
[TBL] [Abstract][Full Text] [Related]
39. Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.
Sana G; Madigan JP; Gartner JJ; Fourrez M; Lin J; Qutob N; Narayan J; Shukla S; Ambudkar SV; Xia D; Rosenberg SA; Gottesman MM; Samuels Y; Gillet JP
J Invest Dermatol; 2019 Sep; 139(9):1985-1992.e10. PubMed ID: 30905807
[TBL] [Abstract][Full Text] [Related]
40. IMP-3 is a novel progression marker in malignant melanoma.
Pryor JG; Bourne PA; Yang Q; Spaulding BO; Scott GA; Xu H
Mod Pathol; 2008 Apr; 21(4):431-7. PubMed ID: 18204432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
